Loading…

Experts share what you need to know about GLP-1-related hair loss as the side-effect gets more attention from researchers About 20 million people across the US , UK, and EU are taking GLP-1 receptor agonists like tirzepatide and semaglutide (Ozempic or Mounjaro are common…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on The Guardian.